Company History

  • December 2010

    Shandong Taibang’s newly built plasma collection station in Yishui county obtained plasma collection license from the Shandong Provincial Health Department and commenced commercial plasma collection.
  • December 2010

    KPMG was appointed by the Board of Directors as the auditor to further enhance the quality of the company’s financial reporting practices.
  • April 2010

    Shandong Taibang was designated as a “National Center of Excellence for New Drug and Technology Development” by the Department of Science and Technology of Shandong province, making it eligible to implement and advance major drug development strategies proposed by China's Ministry of Science and Technology.
  • December 2009

    China Biologic began trading on NASDAQ under the symbol of “CBPO.” Senior management rang the opening bell at the NASDAQ MarketSite on December 15.
FirstPage | PreviousPage | NextPage | LastPage CurrentPageIndex:5 [1] [2] [3] [4] [5] [6] [7] 
© 2014 China Biologic Products, Inc. All Rights Reserved.